On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...